NCT04523285View on ClinicalTrials.gov

A Phase I Study of TQB728 Tablets on Tolerance and Pharmacokinetics

PHASE1UnknownINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 26, 2020

Primary Completion Date

December 31, 2021

Study Completion Date

May 30, 2022

Conditions
Advanced Solid Tumor or Hematologic Tumor
Interventions
DRUG

TQB3728

TQB3728 tablets is a small molecule oral drug.

Trial Locations (1)

510060

RECRUITING

Sun Yat-sen University Cancer Center, Guangzhou

Sponsors
All Listed Sponsors
lead

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

INDUSTRY